BH3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 56.96 EUR 0.49% Market Closed

Market Cap: €4.3B

P	PTC Therapeutics Inc DUS:BH3	US
	Henkel AG & Co KGaA OTC:HENOF	DE
A	Ameren Corp SWB:AE4	US
	Reco International Group Inc XTSX:RGI	CA
	Australian Oil Company Ltd OTC:SGCSF	AU
A	Allegro.eu SA XMUN:AL0	LU

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

94% > 93%

Healthy Operating Margin

12%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-49% > 12%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-13%

Net Margin is Increasing

-80% > -4%

Negative Free Cash Flow Margin

-4%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

-37% > -4%

Positive ROE

21%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

ROIC is Increasing

-34% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.